Categories: AnalyticsCareDataDrugMedtechTechnologyTools
Enhances inclusive patient care and drug access with tools for manufacturers, pharmacies, and prescribers.
Investors 1
Mentions in press and media 7
Date | Title | Description |
21.12.2024 | Apollo Care's Bold Leap: A New Era in Patient Access Solutions | In the bustling heart of Chicago, Apollo Care is making waves. The company, known for its innovative patient access and analytics solutions, has secured a significant growth equity investment from Flexpoint Ford. This partnership is not jus... |
19.12.2024 | Apollo Care Receives Growth Equity Investment from Flexpoint Ford | Apollo Care, a Chicago, IL-based provider of patient access and analytics solutions, received a growth equity investment from Flexpoint Ford.
The amount of the deal was not disclosed. Under the terms of the investment, Flexpoint Ford will t... |
18.12.2024 | Apollo Care Secures Growth Equity Investment from Flexpoint Ford to Accelerate Patient Access and Commercial Solutions Initiatives | Strategic investment from Flexpoint Ford to drive Apollo Care's growth initiatives
Proceeds will be used to expand Apollo Care's innovation pipeline, enhance existing technology, and scale operations
Flexpoint Ford's Jonathan Oka and Elliot... |
11.09.2024 | Bridging the Gap: Innovations in Patient Access and Affordability | In the evolving landscape of healthcare, patient access and affordability stand as towering challenges. The journey to obtain medications can feel like navigating a labyrinth. Many patients find themselves lost in a maze of bureaucracy, cos... |
10.09.2024 | Learn About Recent Developments in Patient Access & Affordability on the Advancements Series | digital medical records
Discover how innovative tools and technologies are making patient access more accessible.
JUPITER, Fla., Sept. 10, 2024 /PRNewswire-PRWeb/ -- Advancements with Ted Danson will focus on improvements in patient access ... |
26.07.2024 | Fannie Mae and Valinor Pharma: A Tale of Strategic Moves in Finance and Pharma**
** | ** In the bustling world of finance and pharmaceuticals, two recent transactions stand out like beacons in the fog. Fannie Mae, a stalwart in the housing finance sector, has priced its fourth Multifamily Connecticut Avenue Securities (MCAS)... |
23.07.2024 | Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million | Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik® (naloxegol)
Valinor Pharma had owned Movantik since early 2023 and leveraged Apollo Care's commercial platform to grow Movantik ... |
Reviews 0